Science Explorer Back to mapMap

Most cited papers from Eastern Hepatobiliary Surgery Hospital

Eastern Hepatobiliary Surgery Hospital

What are the most cited papers from Eastern Hepatobiliary Surgery Hospital?

The most cited paper from Eastern Hepatobiliary Surgery Hospital is "A Long Noncoding RNA Activated by TGF-β Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma" (Ji‐hang Yuan, Fu Yang, Fang Wang et al., 2014), with 1,591 citations. Next come "Circular RNA circMTO1 acts as the sponge of microRNA‐9 to suppress hepatocellular carcinoma progression" (1,349) and "The global burden of liver disease: The major impact of China" (1,315).

Showing 50 of 60 papers. Every paper with more than 373 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 A Long Noncoding RNA Activated by TGF-β Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma Ji‐hang Yuan, Fu Yang, Fang Wang et al. · Cancer Cell Open access 24 Apr 2014 1,591
2 Circular RNA circMTO1 acts as the sponge of microRNA‐9 to suppress hepatocellular carcinoma progression Dan Han, Jiangxue Li, Huamin Wang et al. · Hepatology Open access 18 May 2017 1,349
3 The global burden of liver disease: The major impact of China Fu‐Sheng Wang, Jian‐Gao Fan, Zheng Zhang et al. · Hepatology Open access 28 Aug 2014 1,315
4 Exosome-Transmitted lncARSR Promotes Sunitinib Resistance in Renal Cancer by Acting as a Competing Endogenous RNA Le Qu et al. · Cancer Cell Open access 30 Apr 2016 1,184
5 EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features Taro Yamashita, Junfang Ji, Anuradha Budhu et al. · Gastroenterology Open access 7 Dec 2008 1,162
6 Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy Yizhou Wang, Jun Li, Yong Xia et al. · Journal of Clinical Oncology 28 Jan 2013 1,129
7 Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial Jordi Bruix, Tadatoshi Takayama, Vincenzo Mazzaferro et al. · The Lancet Oncology 8 Sep 2015 1,128
8 Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer Tian Fang, Hongwei Lv, Guishuai Lv et al. · Nature Communications Open access 9 Jan 2018 1,067
9 METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N 6‐methyladenosine‐dependent primary MicroRNA processing Jinzhao Ma, Fu Yang, Chuanchuan Zhou et al. · Hepatology 24 Oct 2016 1,010
10 Mesenchymal stem cells: a new trend for cell therapy Xin Wei, Xue Feng Yang, Zhipeng Han et al. · Acta Pharmacologica Sinica Open access Jun 2013 959
11 COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas Xianwen Ren et al. · Cell Open access 4 Feb 2021 950
12 Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma Jian Yu, Qingguo Xu, Zhenguang Wang et al. · Journal of Hepatology Open access 31 Jan 2018 892
13 Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition) Jian Zhou et al. · Liver Cancer Open access 2020 848
14 Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing Wen Wen, Wenru Su, Hao Tang et al. · Cell Discovery Open access 4 May 2020 789
15 Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma Xiaoguang Li, Wenbo Yao, YA HONG YUAN et al. · Gut 9 Oct 2015 762
16 New knowledge of the mechanisms of sorafenib resistance in liver cancer Yanjing Zhu, Bo Jian Zheng, Hongyang Wang et al. · Acta Pharmacologica Sinica Open access 27 Mar 2017 737
17 Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial Riccardo Antonio Lencioni, Josep Maria Llovet, Guohong Han et al. · Journal of Hepatology Open access 22 Jan 2016 704
18 Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma Jin Hou, Li Lin, Weiping Zhou et al. · Cancer Cell Open access Feb 2011 697
19 Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition) Jian Zhou et al. · Liver Cancer Open access 2018 691
20 Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences Ton Lisman, Robert Jack Porte · Blood 16 Apr 2010 666
21 Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus–Related Hepatocellular Carcinoma Within the Milan Criteria Zhengqing Lei, Jun Li, Dong Wu et al. · JAMA Surgery 18 Nov 2015 650
22 Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans Fu Yang, Ling Zhang, Xisong Huo et al. · Hepatology 18 Jul 2011 640
23 Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits Katharina Brandl, George Plitas, Coralia N. Mihu et al. · Nature Open access 24 Aug 2008 630
24 Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update Francesco Izzo, Vincenza Granata, Roberta Grassi et al. · The Oncologist Open access 19 Jun 2019 585
25 TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma Pengyuan Yang, Qi-Jing Li, Yuxiong Feng et al. · Cancer Cell Open access Sep 2012 564
26 Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma Xin‐Fei Xu, Hao Xing, Jun Shu Han et al. · JAMA Surgery Open access 13 Nov 2018 550
27 Identification of microRNA‐181 by genome‐wide screening as a critical player in EpCAM–positive hepatic cancer stem cells† Junfang Ji, Taro Yamashita, Anuradha Budhu et al. · Hepatology Open access 3 Apr 2009 528
28 Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023 Mohsen Naghavi et al. · The Lancet Open access2,463 authors Oct 2025 500
29 In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus Denghai Zhang, Kun-lun Wu, Xue Zhang et al. · Journal of Chinese Integrative Medicine Open access 19 Feb 2020 498
30 Theranostic Fluorescent Probes Amit Kumar Sharma, Peter Verwilst, Mingle Li et al. · Chemical Reviews ReviewOpen access 29 Feb 2024 486
31 Repression of the Long Noncoding RNA-LET by Histone Deacetylase 3 Contributes to Hypoxia-Mediated Metastasis Fu Yang, Xisong Huo, Shengxian Yuan et al. · Molecular Cell Open access 7 Feb 2013 480
32 Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition) Jian Zhou et al. · Liver Cancer Open access102 authors 2023 474
33 Mutational landscape of intrahepatic cholangiocarcinoma Shan–Shan Zou, Jiarui Li, Huabang Zhou et al. · Nature Communications Open access 15 Dec 2014 464
34 Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial–mesenchymal transition in hepatocellular carcinoma Qingmin Fan, Yingying Jing, Guofeng Yu et al. · Cancer Letters 2 Jun 2014 463
35 Oncofetal long noncoding RNA PVT1 promotes proliferation and stem cell-like property of hepatocellular carcinoma cells by stabilizing NOP2 Fang Wang, Ji‐hang Yuan, Shao-Bing Wang et al. · Hepatology Open access 15 Jul 2014 461
36 EGFR activation limits the response of liver cancer to lenvatinib Haojie Jin et al. · Nature 21 Jul 2021 453
37 Functions of autophagy in normal and diseased liver Mark J. Czaja, Wen-Xing Ding, Terrence M. Donohue et al. · Autophagy Open access 31 Jul 2013 443
38 Pasireotide for Postoperative Pancreatic Fistula Peter J. Allen, Mithat Gönen, Murray F. Brennan et al. · New England Journal of Medicine Open access 21 May 2014 442
39 Bacterial infection is independently associated with failure to control bleeding in cirrhotic patients with gastrointestinal hemorrhage John Goulis, Anastasios Armonis, David Patch et al. · Hepatology Open access May 1998 442
40 The diversified role of mitochondria in ferroptosis in cancer Yue Liu, Shi-Ping Lu, Lei‐Lei Wu et al. · Cell Death and Disease Open access 14 Aug 2023 439
41 Inducing and exploiting vulnerabilities for the treatment of liver cancer Cun Wang et al. · Nature Open access 2 Oct 2019 438
42 The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1 Ji‐hang Yuan, Xiaoning Liu, Tian-tian Wang et al. · Nature Cell Biology 29 May 2017 434
43 Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1 Shengxian Yuan, Jie Wang, Fu Yang et al. · Hepatology 11 May 2015 424
44 Design strategies and application progress of therapeutic exosomes Chunying Liu, Changqing Su · Theranostics Open access 2019 420
45 New insights and perspectives into biological materials for flexible electronics Lili Wang, Di Chen, Kai Jiang et al. · Chemical Society Reviews Review 2017 415
46 Sarcopenia Impacts on Short- and Long-term Results of Hepatectomy for Hepatocellular Carcinoma Thibault Voron, Lambros Tselikas, Daniel Pietrasz et al. · Annals of Surgery 20 Jun 2014 411
47 Suppression of the SLC7A11/glutathione axis causes synthetic lethality in KRAS-mutant lung adenocarcinoma Kewen Hu, Kun Li, Jing Lv et al. · Journal of Clinical Investigation Open access 24 Dec 2019 410
48 Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients Didier Samuel, Henri Bismuth, ALAIN BISMUTH et al. · The Lancet Apr 1991 406
49 Practice guidelines for the pathological diagnosis of primary liver cancer: 2015 update Wen‐Ming Cong, Hong Bu, Jie Chen et al. · World Journal of Gastroenterology Open access 2016 401
50 Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study Qiujin Shen et al. · The Lancet Oncology 25 Jun 2012 399

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.